The use of the health belief model to assess predictors of intent to receive the Covid-19 vaccine and willingness to pay

Datos Bibliográficos

ID23367283
AutoresLi Ping Wong (0000-0002-0107-0532, University of Malaya, autor de correspondencia), Haridah Alias (0000-0002-1830-4761, University of Malaya), Hai Yen Lee (0000-0001-6322-6718, University Malaya Medical Centre), Sazaly AbuBakar (0000-0002-9267-1420, University Malaya Medical Centre)
Año2020
Volumen16
Número9
Páginas2204-2214
Fecha de publicación2020-09-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaHuman Vaccines & Immunotherapeutics (JOURNAL)
Identificadores de la revistaISSN: 2164-5515 • E-ISSN: 2164-554X
EditorialInforma UK Limited (PUBLISHER • GB)
DOI10.1080/21645515.2020.1790279
PMID32730103
OpenAlexW3046058631
IdiomaEN
Citas recibidas136
Referencias citadas19

BACKGROUND: The development of a vaccine against SARS-CoV-2 infection is on the way. To prepare for public availability, the acceptability of a hypothetical COVID-19 vaccine and willingness to pay (WTP) were assessed to provide insights into future demand forecasts and pricing considerations. METHODS: A cross-sectional survey was conducted from 3 to 12 April 2020. The health belief model (HBM) was used to assess predictors of the intent to receive the vaccine and the WTP. RESULTS: A total of 1,159 complete responses was received. The majority reported a definite intent to receive the vaccine (48.2%), followed by a probable intent (29.8%) and a possible intent (16.3%). Both items under the perceived benefits construct in the HBM, namely believe the vaccination decreases the chance of infection (OR = 2.51, 95% CI 1.19-5.26) and the vaccination makes them feel less worry (OR = 2.19, 95% CI 1.03-4.65), were found to have the highest significant odds of a definite intention to take the vaccine. The mean ± standard deviation (SD) for the amount that participants were willing to pay for a dose of COVID-19 vaccine was MYR$134.0 (SD±79.2) [US$30.66 ± 18.12]. Most of the participants were willing to pay an amount of MYR$100 [US$23] (28.9%) and MYR$50 [US$11.5] (27.2%) for the vaccine. The higher marginal WTP for the vaccine was influenced by no affordability barriers as well as by socio-economic factors, such as higher education levels, professional and managerial occupations and higher incomes. CONCLUSIONS: The findings demonstrate the utility of HBM constructs in understanding COVID-19 vaccination intention and WTP.

2019-20 coronavirus outbreak · Coronavirus disease 2019 (COVID-19) · Disease · Economics · Environmental health · Infectious disease (medical specialty) · Outbreak · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) · Vaccination · Willingness to pay · Economic and Environmental Valuation · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Virology